RXI PHARMACEUTICALS CORP NEW - 74979C303
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2014
· Q1 2014
Value (USD)
Total reported value ($000)
$6.539M
QoQ value delta ($000)
-$409K
(-5.89%)
Implied price effect (QoQ)
-5.89%
Shares
Total shares
1,628,040
QoQ shares delta
-5
(-0.0%)
Total shares held by funds (by quarter)
Top holders (Q2 2014)
Top 25 only
Full list
Partial Q2 2014 data: 6 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Broadfin Capital, LLC | 4,810 | 1,126,482 | 0.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 531 | 175,815 | 0.13% |
| CREDIT SUISSE AG/ | 267 | 88,262 | 0.0% |
| VANGUARD GROUP INC | 186 | 61,681 | 0.0% |
| JANE STREET GROUP, LLC | 165 | 38,677 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 107 | 25,171 | 0.0% |
| Spark Investment Management LLC | 107 | 25,300 | 0.02% |
| TANG CAPITAL MANAGEMENT LLC | 78 | 18,245 | 0.04% |
| MORGAN STANLEY | 72 | 16,786 | 0.0% |
| NORTHERN TRUST CORP | 66 | 15,560 | 0.0% |
| CITADEL ADVISORS LLC | 53 | 12,498 | 0.0% |
| GOLDMAN SACHS GROUP INC | 45 | 10,454 | 0.0% |
| UBS AG | 21 | 5,000 | 0.0% |
| Tower Research Capital LLC | 18 | 4,327 | 0.0% |
| BlackRock Investment Management, LLC | 6 | 1,924 | 0.0% |
| BARCLAYS PLC | 4 | 1,100 | 0.0% |
| LADENBURG THALMANN FINANCIAL SERVICES INC | 2 | 376 | 0.0% |
| CITIGROUP INC | 1 | 157 | 0.0% |
| AMERICAN INTERNATIONAL GROUP INC | 0 | 11 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 5 | 0.0% |
| DIMENSIONAL FUND ADVISORS LP | 0 | 61 | 0.0% |
| AMERIPRISE FINANCIAL INC | 0 | 12 | 0.0% |
| GROUP ONE TRADING, L.P. | 0 | 100 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 36 | 0.0% |